A randomized, controlled trial of interferon ALFA-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B Academic Article uri icon

Overview

MeSH Major

  • Hepatitis B
  • Interferon Type I
  • Interferon-alpha
  • Prednisone

abstract

  • In chronic hepatitis B, treatment with interferon alfa-2b (5 million units per day for 16 weeks) was effective in inducing a sustained loss of viral replication and achieving remission, assessed biochemically and histologically, in over a third of patients. Moreover, in about 10 percent of the patients treated with interferon, hepatitis B surface antigen disappeared from serum.

authors

publication date

  • August 2, 1990

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 2195346

Additional Document Info

start page

  • 295

end page

  • 301

volume

  • 323

number

  • 5